Journal of Clinical Epidemiology
Volume 52, Issue 4 , Pages 355-363 , April 1999

Assessing Quality of Life in Clinical Research: From Where Have We Come and Where Are We Going?

  • Sharon Wood-Dauphinee

      Affiliations

    • School of Physical and Occupational Therapy, Montreal, Quebec, Canada
    • Corresponding Author InformationAddress correspondence to: Sharon Wood-Dauphinee, School of Physical and Occupational Therapy, 3654 Drummond Street, Montreal, Quebec, Canada H3G 1Y5

References 

  1. Pigou AC. The Economics of Welfare. London: MacMillan; 1920;
  2. World Health Organization . WHO Constitution. Geneva: WHO; 1948;
  3. Albrecht GL. Subjective health assessment. In:  Jenkinson C editors. Measuring Health and Medical Outcomes. London: UCL; 1994;
  4. Schuessler KF, Fisher GA. Quality of life research and sociology. Ann Rev Soc. 1985;11:129–149
  5. Elkington JR. Medicine and quality of life. Ann Intern Med. 1966;64:711–714
  6. Drewnowski J. On Measuring and Planning the Quality of Life. The Hague: Mouton; 1974;
  7. Erickson R. Welfare as a planning goal. Acta Sociologica. 1974;17:32–43
  8. Andrews FM, Withey SB. Social Indicators of Well Being (American Perspectives on Life Quality). New York: Plenum; 1976;
  9. Campbell A, Converse PE, Rogers W. The Quality of American Life. New York: Russel Sage; 1976;
  10. Patrick DL, Erickson P. What constitutes quality of life? Concepts and dimensions. Drug Ther Res. 1988;13:152–158
  11. Ware JE. Standards for validating health measures (definition and content). J Chron Dis. 1987;40:473–480
  12. Kaplan RM. Quality of life measurement. In:  Karloy P editors. Measurement Strategies in Health Psychology. New York: John Wiley; 1985;
  13. Greer S. The psychological dimension in cancer treatment. Soc Sci Med. 1984;18:345–349
  14. Bullinger M, Anderson R, Cella D, Aaronson N. Developing and evaluating cross cultural instruments from minimum requirements to optimal models. Qual Life Res. 1993;2:451–459
  15. Bowling A. Measuring Disease. A Review of Disease-specific Quality of Life Measurement Scales. Buckingham: Open University; 1995;
  16. In:  Pope A,  Tarlov A editor. Disability in America (Toward a National Agenda for Prevention). Washington, DC: National Academy; 1991;
  17. Bullinger M. International validation and testing of quality of life scales in relation to Germany. In:  Guggenmoos-Holzmann I,  Bloomfield K,  Brenner H,  Flick U editor. Quality of Life and Health (Concepts, Methods and Applications). Berlin: Blackwell Wissenschafts Verlag; 1995;
  18. Berzon RA, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res. 1993;2:367–368
  19. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health. 1990;11:165–183
  20. Bowling A, Brazier J. Quality of life in social science and medicine. Soc Sci Med. 1995;41:1337–1338
  21. Guyatt G, Feeny D, Patrick D. Measuring health related quality of life. Ann Intern Med. 1993;118:622–629
  22. Patrick DL, Bush JW, Chen MM. Towards an operational definition of health. Med Care. 1973;14:6–21
  23. Gilson BS, Gilson JS, Bergner M, Bobbit RA, Kressel S, Pollard WE, et al. The Sickness Impact Profile. Development of an outcome measure of health care. Am J Public Health. 1975;65:1304–1310
  24. Chambers LW, Sackett DL, Goldsmith CH, MacPherson AS, Mcauley RG. Development and application of an index of social function. Health Serv Res. 1976;11:430–441
  25. Hunt SM, McEwen J. The development of a subjective health indicator. Social Health Ill. 1980;2:231–246
  26. Parkerson GR, Gelbach SH, Wagner EH, James SA, Clapp NE, Muhlbaier LH. The Duke and UNC Health Profile (an adult health status instrument for primary care). Med Care. 1981;19:806–828
  27. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepard R, et al.  Measuring the quality of life of cancer patients. A concise QL-Index for use by physicians. J Chron Dis. 1981;34:585–597
  28. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis. 1987;4:593–600
  29. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Hlth Policy 1990; 16: 199–208.
  30. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36) (I. Conceptual framework and item selection). Med Care. 1992;30:473–483
  31. Ware JE, Jobson SA, Davies-Avery A, Brook RH. Conceptualization and measurement of health for adults. In: The Health Insurance Studies Volume. Santa Monica, CA: Rand; 1979;
  32. In:  Stewart AL,  Ware JE editor. Measuring Functioning and Well-being (the Medical Outcomes Study Approach). Durham, NC: Duke University; 1992;
  33. The WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J Mental Hlth 1994; 23: 24–56.
  34. Streiner DL, Norman GR. Health Measurement Scales (A Practical Guide to their Development and Use). Oxford: Oxford University; 1995;
  35. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific life in clinical trials. Can Med Assoc J. 1986;134:889–895
  36. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippincott-Raven; 1996;
  37. McDowell I, Newell C. Measuring Health (A Guide to Rating Scales and Questionnaires). New York: Oxford University; 1987;
  38. Bowling A. Measuring Health (A Review of Quality-of-Life Measurement Scales). Philadelphia: Open University; 1992;
  39. Williams JI, Wood-Dauphinee S. Assessing quality of life (measures and utility). In:  Mosteller R,  Falotico-Taylor J editor. Quality of Life and Technology Assessment. Washington, DC: National Academy; 1989;
  40. Aaronson NK. Quality of life assessment in clinical trials (methodologic issues). Controlled Clin Trials. 1989;10:195S–208S
  41. Erickson P, Patrick DL. Guidelines for selecting quality of life assessment (methodological and practical considerations). J D R J Drug Ther Res. 1988;13:159–163
  42. Osoba D, Aaronson NK, Till JE. A practical guide for selecting quality-of-life measures in clinical trials and practice. In:  Osoba D editors. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC; 1990;
  43. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med. 1993;118:622–629
  44. In:  Staquet M,  Hays R editor. Quality of Life Assessment in Clinical Trials (Methods and Practice). Oxford: Oxford Medical Publications; 1998;
  45. Guyatt GH, Van Zanten SJOV, Feeny DH, Patrick DL. Measuring quality of life in clinical trials (a taxonomy and review). Can Med Assoc J. 1989;140:1441–1448
  46. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  47. McHorney CA, Kosinski M, Ware JE. Comparisons of costs and quality of norms for the SF-36 health survey collected by mail versus telephone. Med Care. 1997;32:551–567
  48. Cook DJ, Guyatt GH, Juniper E, Griffith L, McIlror W, Willan A, et al.  Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma. J Clin Epidemiol. 1993;46:529–534
  49. Weinberger M, Oddone EZ, Samsa G, Landsman PB. Are health-related quality-of-life measures affected by the mode of administration?. J Clin Epidemiol. 1996;49:135–140
  50. Chambers LW, Haight M, Norman G, Macdonald L. Sensitivity to change and the effect of mode of administration in health status measurement. Med Care. 1987;25:470–479
  51. Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease (a review). J Clin Epidemiol. 1992;45:743–760
  52. Allison PJ, Locker D, Feine JS. Quality of life (a dynamic construct). Soc Sci Med. 1997;45:221–230
  53. Breetvelt IS, Van Dam FSAM. Under-reporting by cancer patients (the case of response shift). Soc Sci Med. 1991;32:981–987
  54. Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation Issues. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  55. Guarnaccia PJ. Anthropological perspectives (the importance of culture in the assessment of quality of life). In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  56. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures (literature review and proposed guidelines). J Clin Epidemiol. 1993;46:1417–1432
  57. Ware JE, Gandek BL, Keller SD, and the IQOLA Project Group. Evaluating instruments used cross-nationally: methods from the IQOLA project. In: Spilker B, Ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippincott-Raven; 1996: 681–692.
  58. Wood-Dauphinee S, Gauthier L, Gandek B, Magnan L, Pierre U. Readying a US measure of health status, the SF-36, for use in Canada. Clin Invest Med. 1997;20:224–238
  59. Bullinger M. German translation and psychometric testing of the SF-36 Health Survey (preliminary results from the IQOLA Project). Soc Sci Med. 1995;41:1359–1366
  60. Sullivan M, Karlsson J, Ware JE. The Swedish SF-36 Health Survey (I. Evaluation of data quality and scaling assumptions, reliability and construct validity across general populations in Sweden). Soc Sci Med. 1995;41:1349–1358
  61. Fairclough DL, Gelber RD. Quality of life (statistical issues and analysis). In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  62. Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR. Quality-of-life assessment (can we keep it simple?). J R Statist Soc. 1992;155:353–393
  63. Buck SF. A method of estimation of missing values in multivariate data suitable for use with electronic computers. J R Statist Soc. 1960;20:303–306
  64. Diehr P, Patrick D, Hedrick S, Rothman M, Grembowski D, Raghunathan TE, et al. Including deaths when measuring health status over time. Med Care. 1995;33(Suppl):AS164–AS172
  65. Ware JE, Keller SD. Interpreting general health measures. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  66. Lydick EG, Epstein RS. Clinical significance of quality of life data. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  67. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(Suppl):S178–S189
  68. Jaeschke R, Singer J, Guyatt G. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1991;12:266S–269S
  69. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835–840
  70. McHorney CA. Generic health measurement (past accomplishments and a measurement paradigm for the 21st century). Ann Intern Med. 1997;127:743–750
  71. Nelson E, Wasson J, Kirk J, Keller A, Clark D, Dietrich T, et al.  Assessment of function in routine clinical practice (description of the COOP chart method and preliminary findings). J Chronic Dis. 1987;40(Suppl1):55S–69S
  72. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey (construction of scales and preliminary tests of reliability and validity). Med Care. 1996;34:220–233
  73. Van Straten A, de Haen RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GAM. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP 30). Stroke. 1997;28:2155–2161
  74. McHorney CA, Ware JE, Rogers WR, Raczek A, Lu JF. The validity and related precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results of the Medical Outcomes Study. Med Care. 1992;30(Suppl 5):MS253–MS265
  75. Coste J, Guillemin F, Pouchot J, Fermanian J. Methodological approaches to shortening composite measurement scales. J Clin Epidemiol. 1997;50:247–252
  76. Aaronson NK, Meyerowitz BE, Bard M, Bloom JR, Fawzy IF, Feldstein M, et al.  Quality of life research in oncology. Past achievements and future priorities. Cancer. 1991;67:839–843
  77. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health. 1990;11:165–183
  78. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59–65
  79. Hunt SM. The problem of quality of life. Qual Life Res. 1997;26:205–212
  80. Gill TM, Feinstein AR. A critical appraisal of quality-of-life measures. JAMA. 1994;272:619–626
  81. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care. 1994;11:1109–1126
  82. McGee HM, O’Boyle CA, Hickey A, O’Malley K, Joyce CRB. Assessing the quality of life of the individual (use SEIQoL with a healthy and a gastroenterology unit population). Psychological Med. 1991;21:749–759
  83. Cleary PD. Future directions of quality of life research. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  84. Smith ND. Quality of life studies from the perspective of an FDA reviewing statistician. Drug Info J. 1993;27:617–623
  85. Wu AW, Cagney KA. The role of quality of life assessment in medical practice. In:  Spilker B editors. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippencott-Raven; 1996;
  86. Rubenstein LV, Calkins DR, Young RT, Cleary PD, Fink A, Kosecoff J, et al.  Improving patient function (a randomized trial of functional disability screening). Ann Intern Med. 1989;111:836–842
  87. McVey LJ, Becker PM, Saltz CC, Feussner JR, Cohen HJ. Effect of a geriatric consultation team on functional status of elderly hospitalized patients. A randomized, controlled clinical trial. Ann Intern Med. 1989;110:79–84
  88. Kazis LE, Callahan LF, Meenan RF, Pincus T. Health status reports in the care of patients with rheumatoid arthritis. J Clin Epidemiol. 1990;43:1243–1253
  89. Rubenstein LV, McCoy JM, Cope DW, Barrett PA, Hirsch SH, Messer KS, et al.  Improving patient quality of life with feedback to physicians about functional status. J Gen Intern Med. 1995;10:607–614
  90. Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res. 1998;7:85–91
  91. McHorney CA, Tarlow AR. Individual patient monitoring in clinical practice (are available health status surveys adequate?). Qual Life Res. 1995;4:293–307
  92. O’Boyle CA, McGee H, Hickley A, O’Malley K, Joyce CRB. Individual quality of life in individuals undergoing hip replacement. Lancet. 1992;339:1088–1091
  93. Calman KC. Quality of life in cancer patients (a hypothesis). J Med Ethics. 1984;10:124–127
  94. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire (an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis). J Rheumatol. 1987;14:446–451
  95. Guyatt G, Walter S, Norman G. Measuring change over time (assessing the usefulness of evaluative instruments). J Chron Dis. 1987;40:171–178
  96. Juniper EF, Guyatt GH, Fernie PL, Griffith LE. Measuring quality of life in asthma. Am Rev Resp Dis. 1993;147:832–838
  97. Wright JG, Young NL. The Patient-Specific Index: asking patients what they want. J Bone Joint Surg 1997; 79.A: 974–983.
  98. Ferrans CE, Powers MJ. Quality of life index (development and psychometric properties). Adv Nurs Sci. 1985;8:15–24
  99. Ferrans C. Development of a quality of life index for patients with cancer. Oncol Nurs Forum. 1990;17:15–19
  100. Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of Item Response Theory. Newbury Park, CA: Sage; 1991;
  101. Weiss DJ. Improving measurement quality and efficiency with adaptive testing. Appl Psychol Testing. 1982;6:473–492
  102. Hambleton RK, Swaminathan H. Item Response Theory (Principles and Applications). Boston, MA: Kluwer Nijhoff; 1985;
  103. Iczzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666–674
  104. Selby JV. Linking automated databases for research in managed care. Ann Intern Med. 1997;127:719–724
  105. Liang MH, Shadick N. Feasibility and utility of adding disease-specific outcome measures to administrative databases to improve disease management. Ann Intern Med. 1997;127:739–742
  106. Nerenz DR. Measuring plans and measuring health. Ann Intern Med. 1997;127:751
  107. Ware JE, Davies AR. Monitoring Health Outcomes from the Patients Point of View (A Primer). Kenilworth: Integrated Therapeutics Group Inc; 1995;
  108. Grostin L. Health care information and the protection of personal privacy (ethical and legal considerations). Ann Intern Med. 1997;127:683–690

PII: S0895-4356(98)00179-6

Journal of Clinical Epidemiology
Volume 52, Issue 4 , Pages 355-363 , April 1999

Article Tools